Beauty Rep is a B2B digital platform that connects global beauty and aesthetic brands with dermatology practices, plastic surgery centers, and med spas, streamlining product discovery, purchasing, and marketing into one centralized hub. Pulse 2.0 interviewed Beauty Rep CEO Keri Concannon and COO Olivia Schmid to learn more.
Background of Keri Concannon and Olivia Schmid
Could you tell me more about your background? Concannon and Schmid said:
“Our team blends deep domain expertise in aesthetics, digital commerce, and law. Keri Concannon is a veteran sales leader with 20+ years in the industry, previously holding senior roles at Obagi Medical and serving as AVP of Marketing at Clinical Skin, where she integrated Glytone. Olivia Schmid is a Columbia Law/London Business School grad who built B2B categories at Amazon and led commercial operations for top injectable brands at Galderma and AbbVie (Allergan).”
Formation Of The Company
How did the idea for the company come together? Concannon and Schmid shared:
“We lived the inefficiencies firsthand. While the market was booming, the B2B model remained structurally antiquated with clinics juggling 12+ reps in the middle of their working hours while brands faced sales costs consuming 40–60% of revenue. We saw an opportunity to build a “DTC experience for B2B” that modernizes how brands and practices connect and transact. An extension of the brands infrastructure and a centralized hub for the practices.”
Favorite Memory
What has been your favorite memory working for the company so far? Concannon and Schmid reflected:
“It was witnessing the excitement after a true “lightbulb moment” from one of our partners, someone who runs a high-volume aesthetic practice and also owns a doctor-led skincare brand. Watching him realize that Beauty Rep could simultaneously solve his procurement challenges as a provider and reduce his high cost-to-serve as a brand owner was incredibly validating. It confirmed that our platform isn’t just a tool, it’s essential digital infrastructure for both sides of the medical aesthetics ecosystem.”
Core Products
What are the company’s core products and features? Concannon and Schmid explained:
“Beauty Rep is built on three pillars: Commerce (streamlined ordering and net-terms logic), Enablement (centralized clinical education and marketing assets), and Data Connectivity (real-time demand insights and market analytics).”
Challenges Faced
Have you faced any challenges in your sector of work recently? Concannon and Schmid acknowledged:
“The industry is still not clearly regulated, which has created significant challenges, but that’s changing quickly. We’re building the necessary gatekeeping directly into our technology, rigorously vetting every brand for legitimacy and every practice for proper licensing to ensure a high-trust marketplace.”
Evolution Of The Company’s Technology
How has the company’s technology evolved since launching? Concannon and Schmid noted:
“We moved from a transaction-focused MVP to a connectivity layer. We recently trademarked Aesthetitech, our AI-powered discovery assistant that will enable “conversational shopping” to help practices find the right clinical solutions at scale.”
Significant Milestones
What have been some of the company’s most significant milestones? Concannon and Schmid cited:
“We beat our 2025 forecast early by signing over 10 major brands pre-launch and we successfully closed a Friends & Family fundraise with a majority of female investors. We also got some great press features in WWD, BeautyMatter and other leading industry publications, further validating that what we’re building isn’t just timely, but truly needed.”
Customer Success Stories
Can you share any specific customer success stories? Concannon and Schmid highlighted:
“One of the most validating success stories has been seeing how quickly clinics embrace a more modern purchasing experience when it’s made available to them. For brands that invite their existing accounts onto Beauty Rep, we’re seeing approximately 25% of clinics enroll from the very first outreach email.
What’s been even more interesting is how practices are using the platform. Clinics are actively engaging with educational and marketing resources on their own time, and the majority of orders are being placed outside of traditional business hours. We always believed providers wanted greater flexibility and self-service access to information, ordering, and support, but seeing that behavior reflected in the data has been incredibly validating.
We’ve also seen a meaningful impact on brand growth. By eliminating administrative burden and repetitive account management tasks from their sales teams, one of our brand partners has already exceeded its entire new account forecast for the year, and it’s only June. Rather than spending time processing orders, answering routine product questions, or managing marketing asset requests, their team has been able to focus on higher-value activities that drive practice engagement and business development.
It’s reinforced our belief that practices don’t want less support from brands and reps. They want access to that support when and how it works best for them. Beauty Rep is helping bridge that gap by giving providers the ability to discover, learn, and purchase on their schedule while maintaining direct relationships with their brand partners.”
Funding/Revenue
Are you able to discuss funding and/or revenue metrics? Concannon and Schmid revealed:
“We raised a pre-seed round from a group of business and strategic angel investors, with a majority of that funding coming from carefully selected female partners. As a female-founded venture, the investor base mirrors Beauty Rep’s broader commitment to empowering women in business, particularly in an industry that has historically skewed capital to men. The early funding allowed us to build foundational infrastructure and launch to market. With the core platform now live and onboarding streamlined the company is preparing for an institutional raise this year to accelerate expansion.”
Total Addressable Market (TAM)
What total addressable market (TAM) size is the company pursuing? Concannon and Schmid assessed:
“We are pursuing a $84 billion global aesthetics market growing at a 7% CAGR which is made up of skin care, injectables and aesthetic devices. Our initial U.S. beachhead is $6.8 billion, focusing first on US clinics already engaging in some digital-first ordering patterns.”
Differentiation From The Competition
What differentiates the company from its competition? Concannon and Schmid affirmed:
“Unlike traditional distributors, we are not a reseller. We preserve the direct brand-to-practice relationship, maintain price parity, and handle the medical-grade regulatory workflows that generic B2B marketplaces cannot manage.”
Future Company Goals
What are some of the company’s future goals? Concannon and Schmid emphasized:
“Short term, we are hyper-focused on onboarding top global and foreign brands. Long term, we aim to scale internationally and introduce more and more relevant features and helpful technology.”
Additional Thoughts
Any other topics you would like to discuss? Concannon and Schmid concluded:
“We have quite a few ideas for very cool features that will support brand and KOL relationships… stay tuned!”
